Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (261-270 of 501) with videos related to

Pageof 51
Sort By:
British Journal of Haematology|May 29, 2024
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemiaTamer Othman, Paul Koller, Hoda Pourhassan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the BrainSaul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryan Urak, Miriam Walter, et al.
JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2023
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expressionAshlie M Munoz, Ryan Urak, Ellie Taus, et al.
Pageof 51

Showing results (261-270 of 501) with videos related to

Sort By:
Pageof 51
British Journal of Haematology|May 29, 2024
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemiaTamer Othman, Paul Koller, Hoda Pourhassan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the BrainSaul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryan Urak, Miriam Walter, et al.
JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2023
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expressionAshlie M Munoz, Ryan Urak, Ellie Taus, et al.
Pageof 51